12.5 C
New York
Saturday, November 21, 2026

Eisai Q3 FY2025 slides reveal 109% growth in LEQEMBI sales, strategic oncology investments

Eisai Q3 FY2025 slides reveal 109% growth in LEQEMBI sales, strategic oncology investments

Related Articles

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe

Latest Articles